| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |